
Maverick Ventures
1 Letterman Drive, Building D, San Francisco, CA, 94129, United States
Overview
Maverick Ventures is the venture arm of multi-billion dollar investment firm Maverick Capital. Combining the resources of a global firm with the benefits of an agile, focused team, Maverick Ventures supports entrepreneurs from seed through maturity. With over 30 years of early-stage investment experience, the Maverick Ventures team has funded more than 100 companies in the healthcare, software and deep technology sectors. The highly-experienced team of operating executives and investors at Maverick Ventures generally lead rounds, take board seats and work with management to build successful enterprises.
- Total investments
- 115
- Lead investments
- 29
- Investments · 12mo
- 12
- Active investors
- 11
Sector focus
- Cyber Security
- Finance
- Financial Services
- Health Care
- Venture Capital
Investment portfolio
- Aampere
Participated · Seed · Jul 2026
Founded in 2022 by three engineers from TU Munich, Aampere operates a transactional platform for the secondary used-EV market that combines a self-learning pricing algorithm, a digital condition and history check, and Europe-wide dealer auctions. Sellers (both private and commercial) receive a purchase offer within 48 hours, and Aampere pays before arranging collection from the seller’s home. The company reports selling several thousand EVs per year, more than 25 employees, and revenue that grew fourfold over the past 12 months after a reported 60% annual growth rate for three years. Aampere has positioned itself closer to Auto1’s dealer-auction model rather than listing sites, and competes with other dedicated used-EV platforms. With the new funding, Aampere plans to expand its marketplace across more European markets and scale seller acquisition.
- Nourish
Participated · Series C · May 2026
Nourish operates an AI-native virtual metabolic clinic that pairs more than 10,000 registered dietitians with AI health agents to deliver personalized, insurance-covered care. The company layers lab testing, GLP-1 prescribing and medication management, and virtual medical care into its nutrition-first model to drive sustained behavior change. Nourish reports best-in-class clinical outcomes — including average 8% weight loss, a 1.3 point A1C reduction, a 31 point LDL cholesterol reduction, and a 23 point systolic blood pressure reduction — and estimates over $2,000 in annual cost savings per patient for health plans. Its patient-facing AI agent has hundreds of thousands of monthly active users and its provider-facing AI copilots surface real-time insights and automate administrative work. Nourish has completed millions of appointments, has more than tripled year-over-year, partners with hundreds of leading health plans to cover over 200 million lives, and receives referrals from tens of thousands of providers across more than 250 health systems. The company integrates responsible GLP-1 prescribing into its care model while emphasizing nutrition and behavior support to sustain long-term outcomes.
- Chapter
Participated · Series E · Apr 2026
Chapter offers an AI-native platform that powers licensed advisors to deliver personalized, impartial Medicare plan recommendations and help seniors maximize benefits. The company reviews every Medicare plan nationwide and has deployed products such as the most accurate provider directory and a prescription cost calculator for Medicare. Chapter reported rapid commercial traction in 2025, growing revenue threefold and surpassing $100 million in annual recurring revenue while maintaining flat corporate headcount. It is expanding its product set to launch additional financial products and to help members save across more of their spending. The business positions itself as the leading Medicare navigation option nationwide and partners with organizations to assist seniors with retirement healthcare decisions.
- BlueFlag Security
Led · Series A · Mar 2026
BlueFlag Security develops security solutions for AI-driven systems, focusing on protecting AI models and data pipelines. Its platform helps enterprises detect vulnerabilities, monitor model behavior, and ensure safe deployment of AI applications. The company raised $28 million in a Series A to accelerate its product roadmap and expand adoption. BlueFlag plans to use the capital to scale product development and support customers as organizations build AI security frameworks. The article does not disclose revenue, user metrics, year of founding, or location. No additional operating metrics were provided.
- Daffodil Health
Participated · Series A · Feb 2026
Daffodil Health provides an AI-first, configurable platform that overlays existing claims systems to automate repricing, payment integrity, and real-time claims support for health insurers and third-party administrators. Its transparent benchmarks and pricing logic help payers adopt modern plan designs such as reference-based pricing, narrow or tiered networks, and dynamic copays while avoiding percentage-of-savings middlemen. The company charges a predictable SaaS fee, aligning incentives and enabling faster deployment than legacy vendors. Across current deployments, Daffodil has generated consistent seven-figure margin improvements; one payer saved roughly $4 million in vendor fees during the first year alone. The fresh capital will accelerate product development and broaden market penetration. Headquartered in San Francisco, Daffodil has raised $20.9 million to date, positioning it to scale its payment integrity solution amid rising demand for price transparency and auditability in healthcare.